These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 16258213)

  • 1. A Chinese patient presenting with clinical signs of fulminant type 1 diabetes mellitus.
    Katsumata K; Katsumata K
    Intern Med; 2005 Sep; 44(9):967-9. PubMed ID: 16258213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies to multiple islet autoantigens in patients with abrupt onset type 1 diabetes and diabetes diagnosed with urinary glucose screening.
    Sera Y; Kawasaki E; Abiru N; Ozaki M; Abe T; Takino H; Kondo H; Yamasaki H; Yamaguchi Y; Akazawa S; Nagataki S; Uchigata Y; Matsuura N; Eguchi K
    J Autoimmun; 1999 Sep; 13(2):257-65. PubMed ID: 10479394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies to IA-2 not detected in NOD mice or BB rats.
    DeSilva MG; Jun HS; Yoon JW; Notkins AL; Lan MS
    Diabetologia; 1996 Oct; 39(10):1237-8. PubMed ID: 8897014
    [No Abstract]   [Full Text] [Related]  

  • 4. Autoantigens IA-2 and GAD in Type I (insulin-dependent) diabetes.
    Leslie RD; Atkinson MA; Notkins AL
    Diabetologia; 1999 Jan; 42(1):3-14. PubMed ID: 10027571
    [No Abstract]   [Full Text] [Related]  

  • 5. Autoantibodies associated with presymptomatic insulin-dependent diabetes mellitus in women.
    Whittingham S; Byron SL; Tuomilehto J; Zimmet PZ; Myers MA; Vidgren G; Rowley MJ; Feeney SJ; Koskela P; Tuomilehto-Wolf E; Mackay IR
    Diabet Med; 1997 Aug; 14(8):678-85. PubMed ID: 9272595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GADIA2-combi determination as first-line screening for improved prediction of type 1 diabetes in relatives.
    Dittler J; Seidel D; Schenker M; Ziegler AG
    Diabetes; 1998 Apr; 47(4):592-7. PubMed ID: 9568692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies predicting diabetes mellitus type I in celiac disease.
    Galli-Tsinopoulou A; Nousia-Arvanitakis S; Dracoulacos D; Xefteri M; Karamouzis M
    Horm Res; 1999; 52(3):119-24. PubMed ID: 10725775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of ICA512 antibodies for prediction and diagnosis of type 1 diabetes.
    Mayrhofer M; Rabin DU; Messenger L; Standl E; Ziegler AG
    Exp Clin Endocrinol Diabetes; 1996; 104(3):228-34. PubMed ID: 8817240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies to ICA12 (SOX-13) are not specific for Type I diabetes.
    Steinbrenner H; Lohmann T; Ostendorf B; Scherbaum WA; Seissler J
    Diabetologia; 2000 Nov; 43(11):1381-4. PubMed ID: 11126406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MHC class I chain-related gene-A is associated with IA2 and IAA but not GAD in Swedish type 1 diabetes mellitus.
    Gupta M; Graham J; McNeeny B; Zarghami M; Landin-Olsson M; Hagopian WA; Palmer J; Lernmark A; Sanjeevi CB
    Ann N Y Acad Sci; 2006 Oct; 1079():229-39. PubMed ID: 17130560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concordance between twins for beta-cell autoimmunity.
    Leslie RD; Pyke DA
    Diabetes; 1996 Sep; 45(9):1284. PubMed ID: 8772736
    [No Abstract]   [Full Text] [Related]  

  • 12. IA-2 (islet cell antigen 512) is the primary target of humoral autoimmunity against type 1 diabetes-associated tyrosine phosphatase autoantigens.
    Bonifacio E; Lampasona V; Bingley PJ
    J Immunol; 1998 Sep; 161(5):2648-54. PubMed ID: 9725268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide mapping and characterisation of glycation patterns of the glima 38 antigen recognised by autoantibodies in Type I diabetic patients.
    Roll U; Turck CW; Gitelman SE; Rosenthal SM; Nolte MS; Masharani U; Ziegler AG; Baekkeskov S
    Diabetologia; 2000 May; 43(5):598-608. PubMed ID: 10855535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes-associated autoantibodies in relation to clinical characteristics and natural course in children with newly diagnosed type 1 diabetes. The Childhood Diabetes In Finland Study Group.
    Sabbah E; Savola K; Kulmala P; Veijola R; Vähäsalo P; Karjalainen J; Akerblom HK; Knip M
    J Clin Endocrinol Metab; 1999 May; 84(5):1534-9. PubMed ID: 10323375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How does antibody combination really predict IDDM in the general population? Fortune telling--not fortune spending.
    Pinhas-Hamiel O; Sprecher E; Vardi P
    Diabetes Metab Rev; 1998 Sep; 14(3):252-4. PubMed ID: 9816473
    [No Abstract]   [Full Text] [Related]  

  • 16. Autoantibody against ICA512 did not improve test sensitivity for slowly progressive IDDM in adults.
    Kasuga A; Ozawa Y; Maruyama T; Ishihara T; Amemiya S; Saruta T
    Diabetes Care; 1997 Apr; 20(4):679-80. PubMed ID: 9097008
    [No Abstract]   [Full Text] [Related]  

  • 17. Islet autoantibodies in cord blood from children who developed type I (insulin-dependent) diabetes mellitus before 15 years of age.
    Lindberg B; Ivarsson SA; Landin-Olsson M; Sundkvist G; Svanberg L; Lernmark A
    Diabetologia; 1999 Feb; 42(2):181-7. PubMed ID: 10064098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies to protein tyrosine phosphatase-like proteins in type I diabetes. Overlapping specificities to phogrin and ICA512/IA-2.
    Kawasaki E; Eisenbarth GS; Wasmeier C; Hutton JC
    Diabetes; 1996 Oct; 45(10):1344-9. PubMed ID: 8826969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular immune response to diverse islet cell antigens in IDDM.
    Durinovic-Bellò I; Hummel M; Ziegler AG
    Diabetes; 1996 Jun; 45(6):795-800. PubMed ID: 8635655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does GAD have a unique role in triggering IDDM?
    Baekkeskov S; Kanaani J; Jaume JC; Kash S
    J Autoimmun; 2000 Nov; 15(3):279-86. PubMed ID: 11040068
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.